Table 2.
Clinical variables | Black N (%) | White N (%) | P-Value |
---|---|---|---|
Tumor Site | 0.049a | ||
Oral cavity | 23 (26.4) | 95 (36.4) | |
Pharynx | 25 (28.7) | 86 (33.0) | |
Larynx | 39 (44.8) | 80 (30.7) | |
Stage At Diagnosis | 0.045a | ||
I | 16 (18.4) | 41 (15.7) | |
II | 7 (8.1) | 47 (18.0) | |
III | 11 (12.6) | 48 (18.4) | |
IV | 49 (56.3) | 107 (41.0) | |
Unknown | 4 (4.6) | 18 (6.9) | |
Lymph Node Involvement At Diagnosis | 0.529 | ||
Yes | 45 (51.7) | 117 (44.8) | |
No | 38 (43.7) | 126 (48.3) | |
Unknown | 4 (4.6) | 18 (6.9) | |
Tumor Grade | 0.129 | ||
Well differentiated | 4 (4.6) | 28 (10.7) | |
Moderately differentiated | 59 (67.8) | 154 (59.0) | |
Poorly differentiated | 11 (12.6) | 30 (11.5) | |
Not evaluated | 12 (13.8) | 33 (12.7) | |
Unknown | 1 (1.2) | 16 (6.1) | |
Treatment | 0.233 | ||
Surgery only | 25 (28.7) | 84 (32.2) | |
Radiation and/or chemo only | 29 (33.3) | 60 (23.0) | |
Surgery + radiation and/or chemo | 26 (29.9) | 99 (37.9) | |
Unknownb | 7 (8.1) | 18 (6.9) | |
Total | 87 (100) | 261 (100) |
p-value <0.05 is considered statistically significant,
Data missing for at least one of the three treatment options and includes three Black cases that refused treatment.